Apolipoprotein-1 risk variants and associated kidney phenotypes in an adult HIV cohort in Nigeria
- 24 April 2021
- journal article
- research article
- Published by Elsevier BV in Kidney International
- Vol. 100 (1), 146-154
- https://doi.org/10.1016/j.kint.2021.03.038
Abstract
No abstract availableFunding Information
- National Institutes of Health
- NIAID (R01 AI093234)
- National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK112271)
This publication has 66 references indexed in Scilit:
- Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among NigeriansInternational Urology and Nephrology, 2012
- HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristicsKidney International, 2012
- Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin CThe New England Journal of Medicine, 2012
- Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 geneHuman Genetics, 2010
- Genetics of Focal Segmental Glomerulosclerosis and Human Immunodeficiency Virus–Associated Collapsing Glomerulopathy: The Role of MYH9 Genetic VariationSeminars in Nephrology, 2010
- HIV-infected persons continue to lose kidney function despite successful antiretroviral therapyAIDS, 2009
- Proteinuria, Creatinine Clearance, and Immune Activation in Antiretroviral‐Naive HIV‐Infected SubjectsThe Journal of Infectious Diseases, 2009
- MYH9 is a major-effect risk gene for focal segmental glomerulosclerosisNature Genetics, 2008
- Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, ZambiaAIDS, 2008
- Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney diseaseAIDS, 2008